Health-eBrain Study: Addressing Mood and Cognitive Functioning in Dementia Caregivers
About the Research Project
Program
Award Type
Other
Award Amount
$450,000
Active Dates
April 15, 2016 - July 14, 2017
Grant ID
CA2016602
Co-Principal Investigator(s)
Stacey Kaltman, PhD, AnthroTronix
Goals
The Health-eBrain Study seeks to understand the cognitive functioning of dementia caregivers who are heavily burdened and who are at risk for mood disorders. This virtual longitudinal study is comprised of an intervention Case Management arm and a waitlist control arm. Additionally participants may be selected to participate in a cognitive wellness group where their cognition is solely tracked over time using the DANA Brain Vital app.
Summary
The Health-eBrain Study seeks to understand the cognitive functioning of dementia caregivers who are heavily burdened and who are at risk for mood disorders. This virtual longitudinal study is comprised of an intervention Case Management arm and a waitlist control arm. Additionally participants may be selected to participate in a cognitive wellness group where their cognition is solely tracked over time using the DANA Brain Vital app.
Related Grants
Alzheimer's Disease Research
Mapping Brain Resilience in the Oldest-Old: A Multi-Omic Atlas of Cognitive Protection
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Vivek Swarup, PhD
Current Organization
University of California, Irvine
Mapping Brain Resilience in the Oldest-Old: A Multi-Omic Atlas of Cognitive Protection
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Vivek Swarup, PhD
Current Organization
University of California, Irvine
Alzheimer's Disease Research
Predicting Therapeutic Interventions for Resilience to Brain Aging
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Christina Theodoris, MD, PhD
Current Organization
Gladstone Institutes
Predicting Therapeutic Interventions for Resilience to Brain Aging
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Christina Theodoris, MD, PhD
Current Organization
Gladstone Institutes
Alzheimer's Disease Research
Advancing the Promising Cerebroprotectant AST-004 to Human Clinical Trials
Active Dates
July 02, 2021 - June 30, 2024
Principal Investigator
William Korinek, PhD
Current Organization
Astrocyte Pharmaceuticals
Advancing the Promising Cerebroprotectant AST-004 to Human Clinical Trials
Active Dates
July 02, 2021 - June 30, 2024
Principal Investigator
William Korinek, PhD
Current Organization
Astrocyte Pharmaceuticals